We are live on
!
Find out more
TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
OM
1
Opaleye Management
Boston,
Massachusetts
| $3M | +$2.6M | +333,333 | New |
|
| 2 |
KPF
2
K2 Principal Fund
Toronto,
Ontario, Canada
| $178K | +$155K | +19,783 | New |
|
| 3 |
ACP
3
Acuta Capital Partners
Redwood City,
California
| $171K | +$148K | +19,000 | New |
|
| 4 |
TDC
4
Thompson Davis & Co
Richmond,
Virginia
| $45K | +$39.1K | +5,000 | New |
|
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
| $15K | +$12.8K | +1,632 | New |
|
| 6 |
FMA
6
FNY Managed Accounts
New York
| $13.5K | +$11.7K | +1,500 | New |
|
| 7 |
7
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$47 | +6 | New |
|
| 8 |
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$305 | +39 | New |
|